Neuroprotective activity of isoquinoline alkaloids from of Chilean Amaryllidaceae plants against oxidative stress-induced cytotoxicity on human neuroblastoma SH-SY5Y cells and mouse hippocampal slice culture
- 1 October 2019
- journal article
- research article
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 132, 110665
Abstract
No abstract availableKeywords
Funding Information
- Fondo Nacional de Desarrollo Científico y Tecnológico
- Comisión Nacional de Investigación Científica y Tecnológica
This publication has 39 references indexed in Scilit:
- Caliphruria subedentata (Amaryllidaceae) decreases genotoxicity and cell death induced by β-amyloid peptide in SH-SY5Y cell lineMutation Research - Genetic Toxicology and Environmental Mutagenesis, 2018
- Amaryllidaceae alkaloids as agents with protective effects against oxidative neural cell injuryLife Sciences, 2018
- A key role for MAM in mediating mitochondrial dysfunction in Alzheimer diseaseCell Death & Disease, 2018
- Alzheimer’s disease hypothesis and related therapiesTranslational Neurodegeneration, 2018
- Neuroprotective mechanism of the novel melatonin derivative Neu-P11 in brain ischemia related modelsNeuropharmacology, 2015
- Dihydroagarofuranoid Sesquiterpenes as Acetylcholinesterase Inhibitors from Celastraceae Plants: Maytenus disticha and Euonymus japonicusJournal of Agricultural and Food Chemistry, 2015
- Subthreshold Concentrations of Melatonin and Galantamine Improves Pathological AD-Hallmarks in Hippocampal Organotypic CulturesMolecular Neurobiology, 2015
- Changes in apolar metabolites during in vitro organogenesis of Pancratium maritimumPlant Physiology and Biochemistry, 2010
- Unequal Neuroprotection Afforded by the Acetylcholinesterase Inhibitors Galantamine, Donepezil, and Rivastigmine in SH-SY5Y Neuroblastoma Cells: Role of Nicotinic ReceptorsThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Neurotoxic and neuroprotective effects of the glutamate transporter inhibitor dl-threo-beta-benzyloxyaspartate (dl-TBOA) during physiological and ischemia-like conditionsNeurochemistry International, 2003